HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David A Rizzieri Selected Research

5'-oleoyl cytarabine

12/2014Clinical potential of elacytarabine in patients with acute myeloid leukemia.
4/2008Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David A Rizzieri Research Topics

Disease

28Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2022 - 02/2003
20Neoplasms (Cancer)
10/2022 - 02/2002
19Leukemia
01/2019 - 02/2002
13Lymphoma (Lymphomas)
01/2019 - 07/2002
8Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021 - 05/2008
8Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2013 - 06/2004
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 05/2009
7Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 02/2007
6Infections
01/2020 - 11/2007
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2015 - 02/2002
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2013 - 02/2002
5Burkitt Lymphoma (Burkitt's Lymphoma)
02/2013 - 06/2003
4Multiple Myeloma
01/2022 - 05/2009
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2009 - 02/2002
3Disease Progression
01/2021 - 09/2003
3Bronchiolitis Obliterans Syndrome
01/2021 - 07/2010
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2016 - 05/2008
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2015 - 05/2013
3Hematologic Neoplasms (Hematological Malignancy)
07/2014 - 05/2008
2Hypoalbuminemia
10/2022 - 01/2019
2Primary Myelofibrosis (Myelosclerosis)
07/2022 - 05/2008
2Nausea
01/2021 - 01/2016
2Hodgkin Disease (Hodgkin's Disease)
10/2015 - 09/2003
2Blast Crisis (Blast Phase)
06/2013 - 05/2008
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Critical Illness (Critically Ill)
01/2021
1Sepsis (Septicemia)
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Dysgeusia (Parageusia)
01/2021
1Vomiting
01/2021
1Diarrhea
01/2021
1Delirium
12/2020
1Edema (Dropsy)
01/2019
1Body Weight (Weight, Body)
01/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Bacterial Infections (Bacterial Infection)
07/2017
1Peripheral Nervous System Diseases (PNS Diseases)
02/2017

Drug/Important Bio-Agent (IBA)

7GemcitabineFDA Link
12/2010 - 02/2002
5Pharmaceutical PreparationsIBA
01/2021 - 06/2005
5Rituximab (Mabthera)FDA Link
11/2014 - 06/2003
4Alemtuzumab (Campath)FDA Link
02/2014 - 02/2002
4Monoclonal AntibodiesIBA
05/2011 - 02/2002
4Etoposide (VP 16)FDA LinkGeneric
05/2009 - 03/2003
3tagraxofuspIBA
10/2022 - 12/2016
3Azacitidine (5 Azacytidine)FDA Link
01/2022 - 12/2012
3venetoclaxIBA
01/2022 - 01/2019
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
3Imatinib Mesylate (Gleevec)FDA Link
01/2021 - 10/2008
3Mitoxantrone (Novantrone)FDA LinkGeneric
12/2010 - 02/2002
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2004 - 03/2003
3Dihydrotachysterol (AT 10)IBA
02/2003 - 02/2002
2mivebresibIBA
07/2022 - 01/2021
2Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 12/2014
2CytokinesIBA
01/2020 - 10/2016
2Lenalidomide (CC 5013)FDA Link
02/2017 - 12/2012
25'-oleoyl cytarabineIBA
12/2014 - 04/2008
2AnthracyclinesIBA
12/2014 - 11/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 12/2012
2CD52 AntigenIBA
05/2011 - 02/2002
2MicroRNAs (MicroRNA)IBA
12/2010 - 05/2009
2fludarabineIBA
08/2008 - 02/2003
2Irinotecan (Camptosar)FDA LinkGeneric
04/2008 - 07/2002
2TenascinIBA
10/2005 - 08/2004
1Alanine (L-Alanine)FDA Link
10/2022
1Aspartic Acid (Aspartate)FDA Link
10/2022
1Transaminases (Aminotransferases)IBA
10/2022
1selinexorIBA
01/2022
1Karyopherins (Importin)IBA
01/2022
1sapacitabineIBA
12/2021
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2021
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
01/2021
1CPX-351IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Local Anti-Infective Agents (Antiseptics)IBA
01/2021
1Cytochromes c (Cytochrome c)IBA
01/2021
1Daunorubicin (Cerubidine)FDA LinkGeneric
01/2021
1Alanine Transaminase (SGPT)IBA
01/2019
1HMGB1 Protein (HMG1)IBA
01/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
01/2019
1pomalidomideIBA
01/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2018
1Bendamustine HydrochlorideFDA Link
01/2018
1Bortezomib (Velcade)FDA Link
02/2017

Therapy/Procedure

23Therapeutics
07/2022 - 02/2002
18Cell Transplantation
09/2021 - 10/2008
13Transplantation
07/2017 - 04/2002
12Drug Therapy (Chemotherapy)
12/2016 - 04/2002
6Hematopoietic Stem Cell Transplantation
01/2021 - 08/2010
6Stem Cell Transplantation
02/2017 - 06/2004
4Induction Chemotherapy
12/2021 - 07/2009
4Homologous Transplantation
01/2017 - 02/2013
2Intravenous Infusions
01/2019 - 01/2018
2Autologous Transplantation
11/2014 - 03/2003
2Immunotherapy
11/2014 - 10/2006
2Haploidentical Transplantation
09/2010 - 11/2007
2Radiotherapy
07/2009 - 09/2003
2Organ Transplantation
06/2004 - 06/2003
1Length of Stay
01/2021
1Consolidation Chemotherapy
01/2020